Cover Image

Sternocleidomastoid Muscle Overactivity: A Potentially Critical Contributor to Postural Abnormalities in Parkinson's Disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sha Zhu, Ronghua Hong, Zhuang Wu, Yunjun Bao, Yunping Song, Guojiong Hu, Zhongfei Bai, Feifei Zhu, Zhenhua Liao, Lizhen Pan, Qiang Guan, Zhuoyu Zhang, Lingjing Jin
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Annals of Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Prediction Rule for the Dystonic Spread of Blepharospasm: A 4‐Year Prospective Cohort Study
by: Ziwen Xing, et al.
Published: (2024)

Reconsidering Central and Peripheral Contributions to Propranolol's Anti Tremor Effects in Parkinson's Disease
by: Sijia Zhu, et al.
Published: (2025)

Punctate White Matter Abnormality in Moderate‐to‐Late Preterm Infants
by: Eleanor Kennedy, et al.
Published: (2025)

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative
by: Daniel Weintraub, et al.
Published: (2026)

From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI
by: Kenneth Marek, et al.
Published: (2026)

Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
by: Paulina Gonzalez‐Latapi, et al.
Published: (2026)

Timing of Peri‐Ictal MRI Abnormalities in Status Epilepticus – One Size Does Not Fit All
by: Pilar Bosque Varela, et al.
Published: (2025)

Pleiotropy and the Increasing Complexity of Parkinson's Disease Genetics
by: Jonggeol Kim, et al.
Published: (2025)

Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker‐Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
by: Ethan G. Brown, et al.
Published: (2026)

The Parkinson's Progression Markers Initiative: Why Then? Why Now?
by: Michael J. Fox
Published: (2026)

Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative
by: Lana M. Chahine, et al.
Published: (2026)

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease
by: Verena Dzialas, et al.
Published: (2025)

Heart Rate Profiles During Exercise and Incident Parkinson's Disease
by: Stefan van Duijvenboden, et al.
Published: (2025)

Return of Individual Research Information in the Parkinson's Progression Markers Initiative
by: Thomas F. Tropea, et al.
Published: (2026)

Autonomic Dysfunction and Risk of Mortality in Early‐Onset Parkinson's Disease
by: Capucine Piat, et al.
Published: (2025)

Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's Disease
by: Deepika Dinesh, et al.
Published: (2026)

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson's Disease
by: Shannon Y. Chiu, et al.
Published: (2026)

Reply to “An Apple a Day Will Not Keep the (Parkinson's Disease) Doctor at Bay!”
by: Erik Post, et al.
Published: (2024)

Alterations of Cortical Structure and Neurophysiology in Parkinson's Disease Are Aligned with Neurochemical Systems
by: Alex I. Wiesman, et al.
Published: (2024)

White Matter Microstructural Abnormalities in Neonatal Onset Genetic Epilepsy
by: Amanda G. Sandoval Karamian, et al.
Published: (2026)

Continuous Versus Short EEG After Ischemic Stroke: What cEEG Adds for Detecting Abnormalities and Predicting Post‐Stroke Epilepsy
by: Kai Michael Schubert, et al.
Published: (2026)

Predominance of Ferroptotic Cell Death Mechanisms in Substantia Nigra Neurodegeneration in Parkinson's Disease
by: Yue Jing Heng, et al.
Published: (2026)

Reply to “Urinary α‐Synuclein for Parkinson's Detection: Key Limitations and Future Directions”
by: Laura Müller, et al.
Published: (2025)

Letter Concerning Biallelic Variants in EPG5 Gene Are Associated with Parkinson's Disease
by: Hormos Salimi Dafsari, et al.
Published: (2025)

Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease
by: Sofie Slingerland, et al.
Published: (2025)

Reply to “Reconsidering Central and Peripheral Contributions to Propranolol's Antitremor Effects in Parkinson's Disease”
by: Anouk van der Heide, et al.
Published: (2025)

Patterns of Postictal Abnormalities in Relation to Status Epilepticus in Adults
by: Andrea Enerstad Bolle, et al.
Published: (2025)

Age‐Related Differences in the Association between REM Sleep and the Polygenic Risk for Parkinson's Disease
by: Puneet Talwar, et al.
Published: (2025)

Differential Cognitive Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease
by: Victor A Del Bene, et al.
Published: (2024)

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
by: Zhen Fan, et al.
Published: (2026)

α‐Synuclein‐Related Mitochondria‐Nrf2 Dysfunction in Parkinson's Disease Olfactory Mucosa
by: Daniela Maftei, et al.
Published: (2025)

Daily‐Life, Sensor‐Derived Tremor Measures Are Sensitive to Progression in Early Parkinson's Disease
by: Nienke A. Timmermans, et al.
Published: (2026)

From Topography to Therapy: Rethinking Cognitive Monitoring in GBA1 ‐Linked Parkinson's Disease
by: Meijun Liu
Published: (2025)

Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study
by: Oleksandr Dergai, et al.
Published: (2025)

Alternative Translation Initiation in PRKN Delays the Onset of Parkinson's Disease and Offers a Therapeutic Target
by: Arian Hach, et al.
Published: (2026)

Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade‐Long Longitudinal Analysis
by: Morad Elshehabi, et al.
Published: (2025)

Frequency‐ and Network‐Specific Changes in Functional Connectivity Reflect Pathophysiological Mechanisms across Parkinson's Disease Stages
by: Matteo Conti, et al.
Published: (2026)

Micro‐Doses of DNP Preserve Motor and Muscle Function with a Period of Functional Recovery in Amyotrophic Lateral Sclerosis Mice
by: Renjia Zhong, et al.
Published: (2024)

The Age at Onset of LRRK2 p. Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin
by: Theresa Lüth, et al.
Published: (2026)

Elevated α‐Synuclein Aggregate Levels in the Urine of Patients with Isolated REM Sleep Behavior Disorder and Parkinson's Disease
by: Laura Müller, et al.
Published: (2025)